Assessing Methods for Blood Cell Cytotoxic Responses to Inorganic Nanoparticles and Nanoparticle Aggregates
- 3 November 2008
- Vol. 4 (11) , 2025-2034
- https://doi.org/10.1002/smll.200800199
Abstract
Inorganic nanoparticles (NPs) show great potential for medicinal therapy. However, biocompatibility studies are essential to determine if they are safe. Here, five different NPs are compared for their cytotoxicity, internalization, aggregation in medium, and reactive oxygen species (ROS) production, using tumoral and normal human blood cells. Differences depending on the cell type are analyzed, and no direct correlation between ROS production and cell toxicity is found. Results are discussed with the aim of standardizing the procedures for the evaluation of the toxicity.Keywords
This publication has 38 references indexed in Scilit:
- Synthesis and stealthing study of bare and PEGylated silica micro- and nanoparticles as potential drug-delivery vectorsChemical Engineering Journal, 2008
- Single-walled carbon nanotube interactions with HeLa cellsJournal of Nanobiotechnology, 2007
- Magnetic nanoparticles for drug deliveryNano Today, 2007
- Antibody‐Functionalized Hybrid Superparamagnetic NanoparticlesAdvanced Functional Materials, 2007
- Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cellsBrain Research, 2006
- Essential Roles of Receptor-Interacting Protein and TRAF2 in Oxidative Stress-Induced Cell DeathMolecular and Cellular Biology, 2004
- The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen speciesCell Research, 2004
- Room‐temperature preparation and characterization of poly (ethylene glycol)‐coated silica nanoparticles for biomedical applicationsJournal of Biomedical Materials Research Part A, 2003
- Solid C60: a new form of carbonNature, 1990
- Fluorescent erythrosin B is preferable to trypan blue as a vital exclusion dye for mammalian cells in monolayer culture.Journal of Histochemistry & Cytochemistry, 1984